Clinical Pharmacology & Biopharmaceutics
Open Access

Abstract

Aim of audit: 1. To identify compliance of drug chart writing with BNF guidelines 2. To identify most common errors of prescription writingAction plan after 1st cycle: (APRIL-2022) • Messaging in the junior doctor’s group and highlighting the common errors according to our analysis and requesting them to incorporate the improvement in their day to day practice. • Discussing with colleagues about result of the analysis and encouraging them to minimize the error. Action plan after 2nd cycle Discussing about the analysis with the AMU doctors as majority of the patients are first admitted in the AMU so that the common errors of drug chart writing can be avoided. Emailing all doctors working in the trust to follow the standard guideline while writing the drug chart. JUNE-JULY SUMMARY This QIP comprises of 3 cycles. The action plans recommended have been practically implemented in day-to-day practice. The aim was to help maximum number of doctors follow the bnf guidelines while writing the drug charts, we believe we have been able to achieve that. The third cycle shows significant improvement as compared to the first cycle. The limitations that we need to bear in mind are there is always a scope for manual error, hence 100% improvements are difficult to obtain. The third cycle marks the end of this QIP.

Biography

I am Dr.Madhuja Nath , Graduated From Tver State Medical University Russia. After that I have worked in various multispeciality hospital, in both Public and private sector. Upon gaining significant amount of experience in India, I migrated to UK , now working in NHS as CT1 , in Department of Medicine.